Hong Kong Pharma Digital Technology Holdings Limited
HKPD
$1.07
$0.0050.47%
NASDAQ
| 09/30/2024 | 06/30/2024 | 09/30/2023 | |||
|---|---|---|---|---|---|
| Revenue | 5.55M | 5.55M | 3.50M | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 5.55M | 5.55M | 3.50M | ||
| Cost of Revenue | 4.59M | 4.59M | 2.84M | ||
| Gross Profit | 952.80K | 952.80K | 668.00K | ||
| SG&A Expenses | 440.60K | 440.60K | 497.40K | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -400.00 | -400.00 | 900.00 | ||
| Total Operating Expenses | 5.03M | 5.03M | 3.33M | ||
| Operating Income | 512.60K | 512.60K | 169.70K | ||
| Income Before Tax | 489.40K | 489.40K | 137.10K | ||
| Income Tax Expenses | 75.20K | 75.20K | 12.60K | ||
| Earnings from Continuing Operations | 414.30K | 414.30K | 124.50K | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | 414.30K | 414.30K | 124.50K | ||
| EBIT | 512.60K | 512.60K | 169.70K | ||
| EBITDA | 529.70K | 529.70K | 185.50K | ||
| EPS Basic | 0.04 | 0.04 | 0.02 | ||
| Normalized Basic EPS | 0.03 | 0.03 | 0.01 | ||
| EPS Diluted | 0.04 | 0.04 | 0.02 | ||
| Normalized Diluted EPS | 0.03 | 0.03 | 0.01 | ||
| Average Basic Shares Outstanding | 10.00M | 10.00M | 6.84M | ||
| Average Diluted Shares Outstanding | 10.00M | 10.00M | 6.84M | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||